Department of Biotherapy, Hopital Necker Enfants Malades
Department of Biotherapy, Hopital Necker Enfants Malades
Paris, France1 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Safety and Efficacy of Gene Therapy of FHL Type 3 Caused by Mutations in the Human UNC13D Gene by Transplantation of a Single Dose of Autologous CD34+ Cells Transduced ex Vivo With the UNC13D LV Vector Expressing the UNC13D cDNA | Familial Hemophagocytic Lymphohistiocytosis Type 3 (FHL 3) | Not yet recruiting | Phase 1 / Phase 2 | 2026-05-22 | NCT06736080 |